Displaying drugs 176 - 200 of 2767 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Artemether | 298.3746 C16H26O5 |  | An antimalarial agent used in combination with lumefantrine for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum. | Artemisinin and derivatives |
| Artemotil | 312.406 C17H28O5 |  | Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria... | Artemisinin and derivatives |
| Artenimol | 284.352 C15H24O5 |  | For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB13941. | Artemisinin and derivatives |
| Artesunate | 384.425 C19H28O8 |  | Artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria. | Artemisinin and derivatives |
| Articaine | 284.374 C13H20N2O3S |  | A local anesthetic used for inducing local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. | Amides |
| Arzoxifene | 475.6 C28H29NO4S |  | Investigated for use/treatment in breast cancer, osteoporosis, and endometrial cancer. | Sulfur Compounds |
| Asciminib | 449.84 C20H18ClF2N5O3 |  | An inhibitor of ABL/BCR-ABL1 tyrosine kinase for the treatment of patients with Philadelphia chromosome-positive CML, including those with the T315I mutation. | Bcr-Abl Tyrosine Kinase Inhibitors / Tyrosine Kinase Inhibitors |
| Ascorbic acid | 176.1241 C6H8O6 |  | A vitamin used to correct vitamin C deficiency and to increase the intestinal absorption of iron. | Organic Acids |
| Ascorbyl phosphate | Not Annotated |  | Ascorbyl phosphate is a synthetic form of Vitamin C and is found in different salt forms such as magnesium ascorbyl phosphate and sodium ascorbyl phosphate. These salts are present in... | Vitamin C and analogues |
| Asenapine | 285.77 C17H16ClNO |  | An atypical antipsychotic used to treat patients with bipolar I disorder and patients with schizophrenia. | Diazepines, Oxazepines, Thiazepines and Oxepines |
| Asparagine | 132.1179 C4H8N2O3 |  | Used for nutritional supplementation, also for treating dietary shortage or imbalance. | Amino Acids, Basic / Amino Acids, Diamino / Amino Acids, Neutral |
| Aspartic acid | 133.1027 C4H7NO4 |  | An amino acid commonly found as a component in total parenteral nutrition. | Amino Acids, Acidic / Amino Acids, Dicarboxylic / Excitatory Amino Acids |
| Astemizole | 458.5703 C28H31FN4O |  | A second generation antihistamine used to treat allergy symptoms. | Anti-Allergic Agents / Benzimidazoles / Histamine H1 Antagonists, Non-Sedating |
| Asunaprevir | 748.286 C35H46ClN5O9S |  | An NS3 protease inhibitor used to treat hepatitis C genotype 1b. | Antivirals for treatment of HCV infections / Protease Inhibitors |
| Ataluren | 284.242 C15H9FN2O3 |  | A medication used for the treatment of Duchenne muscular dystrophy. | Musculo-Skeletal System / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B3 inhibitors / Oxazoles / UGT1A9 Substrates |
| Atazanavir | 704.8555 C38H52N6O7 |  | An antiviral protease inhibitor used in combination with other antiretrovirals for the treatment of HIV. | HIV Protease Inhibitors / Oligopeptides / Protease Inhibitors / Pyridines |
| Atenolol | 266.3361 C14H22N2O3 |  | A synthetic beta-1 selective blocker used in the management of hypertension and chronic angina, and to reduce mortality in known or suspected myocardial infarction in hemodynamically stable patients. | Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides |
| Atogepant | 603.525 C29H23F6N5O3 |  | An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches. | Calcitonin Gene-Related Peptide Receptor Antagonists |
| Atomoxetine | 255.3547 C17H21NO |  | A selective norepinephrine reuptake inhibitor (SNRI) used in the management of Attention Deficit Hyperactivity Disorder (ADHD). | Agents producing tachycardia / Agents that produce hypertension |
| Atorvastatin | 558.6398 C33H35FN2O5 |  | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Anticholesteremic Agents / Heptanoic Acids / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Atosiban | 994.19 C43H67N11O12S2 |  | An inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations. | Hormone Antagonists / Tocolytic Agents |
| Atovaquone | 366.837 C22H19ClO3 |  | An antimicrobial indicated for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP) and for the prevention and treatment of Plasmodium falciparum malaria. | Biguanides |
| Atractylodes japonica root | Not Annotated |  | Not Annotated | Not Annotated |
| Atracurium | Not Annotated |  | A neuromuscular blocker indicated to relax muscles during mechanical ventilation under general anesthesia or intubation. | Benzylisoquinolines / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists |
| Atracurium besylate | 1243.49 C65H82N2O18S2 |  | A non-depolarizing neuromuscular blocker used to facilitate endotracheal intubation and relax skeletal muscles during surgery. | Benzylisoquinolines / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists |
Displaying drugs 176 - 200 of 2767 in total